Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Cellular & Molecular Immunology
|
July 20, 2021
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Timothy N J Bullock
Journal of Leukocyte Biology
|
June 2, 2012
Editorial: (CD)40 winks to prevent CD8+ T cell lethargy
Timothy N J Bullock
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2014
IL-27 and the generation of CD8+ T-cell responses to peptide vaccines
Timothy N J Bullock
Clinical and Translational Science
|
August 10, 2020
Fundamentals of Cancer Immunology and Their Application to Cancer Vaccines
Timothy N J Bullock
Cellular & Molecular Immunology
|
June 2, 2022
Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Timothy N J Bullock
Frontiers in Immunology
|
February 14, 2014
Metabolic influences that regulate dendritic cell function in tumors
Han Dong, Timothy N J Bullock
Journal of Immunology (Baltimore, Md. : 1950)
|
January 7, 2005
Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells
Timothy N J Bullock, Hideo Yagita
Cancers
|
June 10, 2023
Ready for Prime Time? Dendritic Cells in High-Grade Gliomas
Claire A Conarroe, Timothy N J Bullock
Frontiers in Immunology
|
May 6, 2014
The role of tumor/dendritic cell interactions in the regulation of anti-tumor immunity: the good, the bad, and the ugly
Kristian Michael Hargadon, Timothy N J Bullock
Cancer Immunology, Immunotherapy : CII
|
January 16, 2021
Therapeutic vaccination targeting CD40 and TLR3 controls melanoma growth through existing intratumoral CD8 T cells without new T cell infiltration
Aaron D Stevens, Timothy N J Bullock
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Cellular & Molecular Immunology
|
July 20, 2021
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Timothy N J Bullock
Journal of Leukocyte Biology
|
June 2, 2012
Editorial: (CD)40 winks to prevent CD8+ T cell lethargy
Timothy N J Bullock
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2014
IL-27 and the generation of CD8+ T-cell responses to peptide vaccines
Timothy N J Bullock
Clinical and Translational Science
|
August 10, 2020
Fundamentals of Cancer Immunology and Their Application to Cancer Vaccines
Timothy N J Bullock
Cellular & Molecular Immunology
|
June 2, 2022
Correction: CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies
Timothy N J Bullock
Frontiers in Immunology
|
February 14, 2014
Metabolic influences that regulate dendritic cell function in tumors
Han Dong, Timothy N J Bullock
Journal of Immunology (Baltimore, Md. : 1950)
|
January 7, 2005
Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells
Timothy N J Bullock, Hideo Yagita
Cancers
|
June 10, 2023
Ready for Prime Time? Dendritic Cells in High-Grade Gliomas
Claire A Conarroe, Timothy N J Bullock
Frontiers in Immunology
|
May 6, 2014
The role of tumor/dendritic cell interactions in the regulation of anti-tumor immunity: the good, the bad, and the ugly
Kristian Michael Hargadon, Timothy N J Bullock
Cancer Immunology, Immunotherapy : CII
|
January 16, 2021
Therapeutic vaccination targeting CD40 and TLR3 controls melanoma growth through existing intratumoral CD8 T cells without new T cell infiltration
Aaron D Stevens, Timothy N J Bullock
Page
of 6